English
This Project is not specific to Greece. For more details, please visit OpenAIRE Explore.
Link with research outputs.
Please log in first and try again.
GETUG-AFU 25/PEACE 3: Personalized treatment of patients with metastatic castrate-resistant prostate cancer (MCRPC) receiving docetaxel, using either early switch to cabazitaxel or maintenance treatment with docetaxel plus radium-223, based on circulating tumor cell (CTCs) enumeration.
FunderInstitut National du Cancer
Funded underPHRC
Call for proposalPHRC13
Project codeINCa-DGOS-7193
Open Access mandatePublications: NoResearch data: No
Identifiers
Description
N/A
Partners (15)
Start a new DMP in Loading
